Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2011-10-27Clinical Trial Update: Stress-relief Management for Treatment of Late Complications in Type 2 Diabetes [NA]
This is a clinical trial update from Heidelberg University about stress-relief management for late complications in type 2 diabetes; the stu…
-
CLINICAL_TRIALS trial_result · 2011-10-26Clinical Trial Update: A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate [Phase 3]
A Phase 3 randomized, double-blind, placebo-controlled study evaluated BI 1356 in patients with Type 2 diabetes who cannot take metformin, w…
-
CLINICAL_TRIALS trial_result · 2011-10-26Clinical Trial Update: A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus [Phase 2]
A Phase 2 study of LY2599506, a glucokinase activator, in type 2 diabetes mellitus was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2011-10-26Clinical Trial Update: A Study of LY2599506 in Patients With Type 2 Diabetes [Phase 2]
Phase 2 study of LY2599506 in type 2 diabetes was terminated; results were posted in 2011.
-
CLINICAL_TRIALS research · 2011-10-26Clinical Trial Update: Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management Strategy
This clinical trial update describes a staged management strategy to improve glycemic and blood pressure control in adults with Type 2 diabe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2011-10-26Clinical Trial Update: Self-monitoring of Blood Glucose in Insulin-treated Patients With Type 2 Diabetes [NA]
Clinical trial update examining the effect of self-monitoring of blood glucose in insulin-treated patients with Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2011-10-25Clinical Trial Update: Lifestyle Modification Program to Reduce Risk of Coronary Heart Disease in Latina Women With Diabetes [NA]
This update reports a completed clinical trial evaluating a lifestyle modification program designed to reduce the risk of coronary heart dis…
-
CLINICAL_TRIALS trial_result · 2011-10-25Clinical Trial Update: Cabergoline Effect on Blood Sugar in Type 2 Diabetics [NA]
A clinical trial assessing the effect of cabergoline on blood sugar in patients with type 2 diabetes; the current status of the trial is unk…
-
CLINICAL_TRIALS trial_result · 2011-10-21Clinical Trial Update: Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy Participants [Phase 1]
Phase 1 bioequivalence study comparing 2.5 mg saxagliptin and 500 mg metformin tablets, including a fixed-dose combination tablet, in health…
-
CLINICAL_TRIALS trial_result · 2011-10-21Clinical Trial Update: Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy [NA]
Completed clinical trial evaluating rosiglitazone's effects on renal hemodynamics and proteinuria in adults with type 2 diabetes and overt d…
-
CLINICAL_TRIALS research · 2011-10-21Clinical Trial Update: Educative Intervention to Improve Type 2 Diabetes Mellitus Control in Corrientes [NA]
A clinical trial update notes completion of a study evaluating an educative intervention to improve Type 2 diabetes mellitus control in Corr…
-
CLINICAL_TRIALS trial_result · 2011-10-20Clinical Trial Update: Effects of Food Advanced Glycation Endproducts on Vascular Function in Diabetes [NA]
A completed clinical trial evaluated whether dietary advanced glycation endproducts affect vascular function in individuals with Type 2 Diab…
-
FDA approval · 2011-10-19FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for BYETTA (exenatide) submitted by AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2011-10-17Clinical Trial Update: Drug-drug Interaction Study of Dapagliflozin With Voglibose in Japanese Type 2 Diabetes Mellitus Patients [Phase 1]
This report documents a Phase 1 drug-drug interaction study of dapagliflozin with voglibose in Japanese patients with Type 2 Diabetes Mellit…
-
CLINICAL_TRIALS trial_result · 2011-10-17Clinical Trial Update: MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2) [Phase 3]
A Phase 3 factorial trial evaluated the safety and glucose-lowering effects of co-administering MK0431 with pioglitazone in adults with Type…
-
CLINICAL_TRIALS research · 2011-10-14Clinical Trial Update: Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 clinical trial evaluating high-dose Symlin (pramlintide) for Type 2 Diabetes Mellitus; the current status of the trial is unknown.
-
CLINICAL_TRIALS trial_result · 2011-10-13Clinical Trial Update: Enhancing Support for Women With Type 2 Diabetes: Follow-Up
This is a completed clinical trial update reporting a follow-up study aimed at enhancing support for women with Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: Resistant Hypertension in Patients With Type-II-Diabetes Mellitus
Clinical trial NCT01056367 investigating treatment for resistant hypertension in patients with type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: A Study Of PF-05175157 In Healthy Volunteers [Phase 1]
Pfizer completed a Phase 1 trial of PF-05175157 in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: Organization Program of DiabEtes INsulIN ManaGement [Phase 4]
A Phase 4 clinical trial update from the Chinese Diabetes Society on an insulin management program for Type 2 Diabetes Mellitus; the status …
-
CLINICAL_TRIALS trial_result · 2011-10-07Clinical Trial Update: The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM) [Phase 1]
A Phase 1 clinical trial investigating the role of endogenous GLP-1 in Type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2011-10-06Clinical Trial Update: Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg [Phase 3]
Phase 3 trial evaluating 24-hour glucose control with saxagliptin added to metformin XR vs uptitrated metformin XR in adults with type 2 dia…
-
CLINICAL_TRIALS trial_result · 2011-10-06Clinical Trial Update: Caloric Restriction and Insulin Secretion [NA]
Completed clinical trial investigating caloric restriction and its effect on insulin secretion in individuals with morbid obesity and type 2…
-
CLINICAL_TRIALS trial_result · 2011-10-04Clinical Trial Update: Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy [Phase 2]
Phase 2 trial assessing the safety and efficacy of XOMA 052 in adults with type 2 diabetes on stable metformin therapy has completed.
-
CLINICAL_TRIALS trial_result · 2011-10-04Clinical Trial Update: Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Type 2 Diabetes Mellitus [Phase 1, Phase 2]
Completed safety and pharmacokinetics study of XOMA 052 in subjects with type 2 diabetes mellitus (Phase 1/2).